Ironwood Pharmaceuticals Inc. (IRWD) is set to bring smile on the investors face as Analysts sets mean Target price of $10.50

At the end of the latest market close, Ironwood Pharmaceuticals Inc. (IRWD) was valued at $9.93. In that particular session, Stock kicked-off at the price of $9.94 while reaching the peak value of $10.80 and lowest value recorded on the day was $9.935. The stock current value is $10.26.

Recently in News on October 22, 2020, Ironwood Pharmaceuticals to Host Third Quarter 2020 Investor Update Call. Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced it will host its third quarter 2020 investor update conference call and webcast at 4:30 p.m. Eastern Time on Thursday, November 5, 2020. Individuals interested in participating in the call should dial (833) 350-1432 (U.S. and Canada) or (647) 689-6932 (international) using conference ID number and event passcode 2794527. To access the webcast, please visit the Investors section of Ironwood’s website at at least 15 minutes prior to the start of the call to ensure adequate time for any software downloads that may be required. You can read further details here

My Next COVID-19 Stock Alert Poised For Triple Digit Moves

Get Ready for my next COVID-19 stock idea. I have been very fortunate in discovering biotech, therapeutic and diagnostic companies within the COVID-19 space, before wall street catches on. Our goal for our members is to get our Alert’s first before the crowd.    

>> Sign Up Now to Get Name & Ticker Symbol of Next Triple-Digit Gainer <<


Ironwood Pharmaceuticals Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $14.06 on 01/06/20, with the lowest value was $7.99 for the same time period, recorded on 03/18/20.

Ironwood Pharmaceuticals Inc. (IRWD) full year performance was -6.13%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Ironwood Pharmaceuticals Inc. shares are logging -27.23% during the 52-week period from high price, and 28.41% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $7.99 and $14.10.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 3429314 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Ironwood Pharmaceuticals Inc. (IRWD) recorded performance in the market was -22.92%, having the revenues showcasing 1.68% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 1.60B, as it employees total of 317 workers.

Specialists analysis on Ironwood Pharmaceuticals Inc. (IRWD)

During the last month, 0 analysts gave the Ironwood Pharmaceuticals Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on, the moving average of the company in the 100-day period was set at 9.91, with a change in the price was noted +0.95. In a similar fashion, Ironwood Pharmaceuticals Inc. posted a movement of +10.20% for the period of last 100 days, recording 1,944,483 in trading volumes.

Trends and Technical analysis: Ironwood Pharmaceuticals Inc. (IRWD)

Raw Stochastic average of Ironwood Pharmaceuticals Inc. in the period of last 50 days is set at 75.12%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 71.20%. In the last 20 days, the company’s Stochastic %K was 57.72% and its Stochastic %D was recorded 51.86%.

Now, considering the stocks previous presentation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -22.92%. Additionally, trading for the stock in the period of the last six months notably improved by 0.98%, alongside a downfall of -6.13% for the period of the last 12 months. The shares increased approximately by 8.00% in the 7-day charts and went up by 8.00% in the period of the last 30 days. Common stock shares were driven by 1.68% during last recorded quarter.

Get The Best Stocks To Trade Every Day!

Join now to get the pre-market morning brief 100% free